NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News $16.42 +0.92 (+5.94%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$16.37 -0.05 (-0.30%) As of 07/18/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PSIL alerts:Sign Up Key Stats Today's Range$15.57▼$16.5050-Day Range$11.65▼$16.4252-Week Range$7.14▼$16.50Volume34,489 shsAverage Volume14,994 shsMarket Capitalization$12.32 millionAssets Under Management$11.62 millionDividend Yield2.01%Net Expense Ratio0.99%Aggregate RatingModerate Buy ETF Overview The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares. Read More AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.56%0.51%0.53%Other Expenses2.35%0.57%0.56%0.59%0.56%Total Expense2.95%0.74%0.76%0.74%0.73%Fee Waiver-1.96%-0.76%-0.66%-0.71%-0.63%Net Expense0.99%0.60%0.63%0.58%0.60% Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address PSIL ETF News HeadlinesAdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Up 3.1% - What's Next?July 17 at 4:15 AM | americanbankingnews.comNo Trippin’: Trump Trade Pushes PSIL, VCAR HigherNovember 15, 2024 | finance.yahoo.comPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. | Paradigm Press (Ad)DRUG Enhances Buzz for Psilocybin, Psychedelic ETFsOctober 18, 2024 | finance.yahoo.comAdvisorShares Psychedelics ETF (ARCA:PSIL), Short Interest ReportSeptember 12, 2024 | benzinga.comAdvisorShares Announces Reverse Split of ETFAugust 30, 2024 | finance.yahoo.comSee More Headlines PSIL ETF - Frequently Asked Questions How have PSIL shares performed this year? AdvisorShares Psychedelics ETF's stock was trading at $10.98 on January 1st, 2025. Since then, PSIL shares have increased by 49.5% and is now trading at $16.42. How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AdvisorShares Psychedelics ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that AdvisorShares Psychedelics ETF investors own include Tilray Brands (TLRY), Bright Minds Biosciences (DRUG), Las Vegas Sands (LVS), NVIDIA (NVDA), Archer Aviation (ACHR), Blade Air Mobility (BLDE) and Blink Charging (BLNK). Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings27 Fund Statistics Assets Under Management$11.62 million Average Daily Volume$0.00 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume12 Put Options10 Call Options12 Short Interest13,900 shs Miscellaneous Outstanding Shares750,000Beta0.93 Creation Fee$500.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 PSIL Holdingsatai Life Sciences (NASDAQ:ATAI)Holding Weight: 9.43%NRx Pharmaceuticals (NASDAQ:NRXP)Holding Weight: 8.06%Mind Medicine (MindMed) (NASDAQ:MNMD)Holding Weight: 7.69%Cybin Inc.Holding Weight: 7.28%Alkermes (NASDAQ:ALKS)Holding Weight: 7.11%Sage Therapeutics (NASDAQ:SAGE)Holding Weight: 7.00%COMPASS Pathways (NASDAQ:CMPS)Holding Weight: 5.86%GH Research (NASDAQ:GHRS)Holding Weight: 5.67%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 5.67%Quantum BioPharma Ltd.Holding Weight: 5.67%Full Holdings DetailsPSIL Sector ExposurePSIL Industry Exposure This page (NYSEARCA:PSIL) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSIL Stock Alerts